Clinical trial
Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy
NCT01869309 is registered in ClinicalTrials.gov with LifeBridge Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy
- Lead sponsor
- LifeBridge Health
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- December 31, 2016
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.